Article in Lawyer Monthly – Kerman & Co advise Zhejiang Silk Road Fund as new investor in US$100 million B Series Round in CMR Surgical Ltd
October 1, 2018
“Thought to be Europe’s largest fundraising to date in the medical devices industry.”
Kerman & Co are delighted to feature in The Lawyer Monthly’s “What’s happening in the world of M&A and IPOs” transactions this month, in respect of our involvement representing Zhejiang Silk Road Fund, a private equity fund principally sponsored and managed by Zhejiang United Investment Group, China (ZUIG) as a new investor in the US$100 million B Series Round in CMR Surgical Limited.
To read further details of the published transaction and an interview with Paul Gilks (Partner, Corporate) and Coral Yu (Associate Solicitor, Corporate) please click here.